Basic info
Industry
biotechnology research
Sectors
Biotechnology
Gene Therapy
Cell Therapy
Spinal Muscular Atrophy
CNS Diseases
Lentivirus
Health Care
AAV
Therapeutics
Hemophilia
Liver-directed Diseases
Manufacturing
Eye Diseases
Date founded
2019
Funding rounds raised
Total raised
$10M
from 7 investors over 7 rounds
E
Exegenesis Bio Inc. raised undisclosed on February 2, 2021
Investors: Hillhouse Capital Management, 凯泰资本, Legend Capital, 博远资本 and LYFE Capital
E
Exegenesis Bio Inc. raised $10M on October 21, 2019
Investors: K2VC 险峰 and 凯泰资本